Ads
related to: sickle cell nih research
Search results
Results From The WOW.Com Content Network
Sickle cell disease (SCD), also simply called sickle cell, is a group of hemoglobin-related blood disorders typically inherited. The most common type is known as sickle cell anemia. It results in an abnormality in the oxygen-carrying protein haemoglobin found in red blood cells.
Research. Rodgers is a physician-scientist who studies diseases of bone marrow and is best known for his work on the molecular genetics of hemoglobinopathies and on developing a treatment for sickle cell anemia. He was a major contributor to the development of hydroxyurea therapy, which was approved by the FDA in 1998.
United States. President. Beverley Francis-Gibson. Website. www.sicklecelldisease.org. The Sickle Cell Disease Association of America, Inc. ( SCDAA) is a nonprofit organization with the sole purpose of supporting research, education and funding of individuals, families those who are impacted by sickle cell disease .
FDA approves cure for sickle cell disease, the first treatment to use CRISPR. Berkeley Lovelace Jr. and Marina Kopf. December 8, 2023 at 10:19 AM. The Food and Drug Administration on Friday ...
Marilyn Hughes Gaston (born 31 January 1939) [1] [2] is a physician and researcher. She was the first black woman to direct the Bureau of Primary Health Care in the U.S. Health Resources and Services Administration. [3] She is most famous for her work studying sickle cell disease (SCD).
Eye examination. Treatment. Medical, laser and surgery. Sickle cell retinopathy can be defined as retinal changes due to blood vessel damage in the eye of a person with a background of sickle cell disease. It can likely progress to loss of vision in late stages due to vitreous hemorrhage or retinal detachment. [1]
Sickle cell trait describes a condition in which a person has one abnormal allele of the hemoglobin beta gene (is heterozygous), but does not display the severe symptoms of sickle cell disease that occur in a person who has two copies of that allele (is homozygous).
She became Chief of the Molecular Cell Biology Section of NIDDK in 1994, and Dean of the NIH's Foundation for Advanced Education in the Sciences (FAES) in 1999. Noguchi studies the underlying genetics, metabolism, and treatment of sickle cell disease, in particular sickle hemoglobin polymerization.
He identified that sickle cell emerged around 7,000 years ago in Africa. [2] Rotimi joined the National Institutes of Health in 2007, where he became founding director of the Trans-NIH Center for Research on Genomics and Global Health.
He served on numerous NIH study sections and review panels including the Parent Committee for the National Sickle Cell Anemia Program. In 1982, he joined the faculty of the University of Southern California as Professor of Chemistry where he pursued research on nonlinear optics and nonlinear optical materials and on DNA mutagenesis ...
Ads
related to: sickle cell nih research